Brought to you by 
AeroGen nets $44.7mm in IPO
11 Apr 2011
Executive Summary
Pulmonary controlled-release drug delivery company AeroGen completed its initial public offering, netting $44.7mm through the sale of 4.14mm common shares (including the overallotment) at $12 apiece.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Pulmonary
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com